Literature DB >> 14979107

[Aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio in health surveillance of workers exposed to vinyl chloride monomer: preliminary results].

L Di Lorenzo1, M Corfiati, D Bulfaro, G Liuzzi, M Zenzola, L Soleo.   

Abstract

An AST/ALT ratio > 1 is predictive of liver fibrosis and cirrhosis in patients with chronic hepatitis C virus infection. The aim of this case-control study is to assess AST/ALT ratio in 150 workers exposed to VCM (E) from the beginning of the 1960s to the end of the 1990s. The non-exposed group (NE) consists in 150 male workers employed in the production of a food industry. At least since 1983 exposed subjects worked at VCM environmental concentrations < 3 ppm. All the workers underwent venous blood collection for assessment of AST and ALT. Exposed workers presented mean AST/ALT ratio and frequency of AST/ALT ratio > 1 significantly higher than non-exposed. The mean AST/ALT ratio results significantly higher in the exposed group, also after stratification for alcohol consumption. In exposed workers who consume alcoholic beverages and are operating since before 1983 AST/ALT ratio is significantly and positively influenced only by the working age until 1983. If these results will be confirmed, AST/ALT ratio could be proposed to be included in the periodic medical surveillance of VCM workers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14979107

Source DB:  PubMed          Journal:  G Ital Med Lav Ergon        ISSN: 1592-7830


  2 in total

1.  Liver function assessment in workers exposed to vinyl chloride.

Authors:  Marco Maroni; Anna Clara Fanetti
Journal:  Int Arch Occup Environ Health       Date:  2005-08-10       Impact factor: 3.015

2.  The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes.

Authors:  Giacomo Zoppini; Vittorio Cacciatori; Carlo Negri; Vincenzo Stoico; Giuseppe Lippi; Giovanni Targher; Enzo Bonora
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.